Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Goldfarb

Showing results (81-90 of 274) with videos related to

Pageof 28
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 10, 2006
Strategies for preventing calcium oxalate stonesVadim A Finkielstein, David S Goldfarb
Journal of the American Society of Nephrology : JASN|August 9, 2014
A nomogram for the prediction of kidney stone recurrenceBrian H Eisner, David S Goldfarb
The Virtual Mentor : VM|December 11, 2012
Hyperkalemia: newer considerationsAmar D Bansal, David S Goldfarb
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2014
Dysphoria induced in dialysis providers by secondary hyperparathyroidismIrfana H Soomro, David S Goldfarb
Urology|February 8, 2020
Vitamin D and Kidney StonesMichael L Schulster, David S Goldfarb
Annals of Internal Medicine|November 6, 2023
Thiazides do not affect mortality but may reduce CV events vs. nondiuretic antihypertensive drugs at up to 5 yAnuj A Patel, David S Goldfarb
Current Opinion in Nephrology and Hypertension|December 3, 2019
Nephrolithiasis in women: how different from men?Lada Beara-Lasic, David S Goldfarb
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2003
The association of nephrolithiasis with cystic fibrosisEric M Gibney, David S Goldfarb
Seminars in Dialysis|September 15, 2006
The role of continuous renal replacement therapy in the treatment of poisoningJeffrey W Goodman, David S Goldfarb
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 7, 2006
Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sicknessDavid E Leaf, David S Goldfarb
Pageof 28

Showing results (81-90 of 274) with videos related to

Sort By:
Pageof 28
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 10, 2006
Strategies for preventing calcium oxalate stonesVadim A Finkielstein, David S Goldfarb
Journal of the American Society of Nephrology : JASN|August 9, 2014
A nomogram for the prediction of kidney stone recurrenceBrian H Eisner, David S Goldfarb
The Virtual Mentor : VM|December 11, 2012
Hyperkalemia: newer considerationsAmar D Bansal, David S Goldfarb
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2014
Dysphoria induced in dialysis providers by secondary hyperparathyroidismIrfana H Soomro, David S Goldfarb
Urology|February 8, 2020
Vitamin D and Kidney StonesMichael L Schulster, David S Goldfarb
Annals of Internal Medicine|November 6, 2023
Thiazides do not affect mortality but may reduce CV events vs. nondiuretic antihypertensive drugs at up to 5 yAnuj A Patel, David S Goldfarb
Current Opinion in Nephrology and Hypertension|December 3, 2019
Nephrolithiasis in women: how different from men?Lada Beara-Lasic, David S Goldfarb
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2003
The association of nephrolithiasis with cystic fibrosisEric M Gibney, David S Goldfarb
Seminars in Dialysis|September 15, 2006
The role of continuous renal replacement therapy in the treatment of poisoningJeffrey W Goodman, David S Goldfarb
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 7, 2006
Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sicknessDavid E Leaf, David S Goldfarb
Pageof 28